Matthew Johnson

Matthew Johnson is a prominent psychiatrist and neuroscientist specializing in psychedelic research and consciousness studies. As a Professor at Johns Hopkins School of Medicine, he has established himself as a leading figure in investigating the therapeutic potential of psychedelics, particularly psilocybin and other compounds.

He directs the Center for Psychedelic and Consciousness Research, where his team conducts rigorous clinical trials examining how psychedelics can be used to treat various psychiatric conditions including addiction, depression, and end-of-life anxiety. Johnson's work has contributed significantly to the scientific renaissance of psychedelic research and has helped legitimize this field within mainstream academic medicine.

His research combines neurobiology, psychology, and clinical methodology to understand both the mechanisms of action and therapeutic applications of psychedelic compounds.